All In Biotech

Drug Trial Radar · NCT06545916

Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption in Subjects Diagnosed With Moderate to Severe Alcohol Use Disorder and Seeking Treatment

Last checked: Nov 19, 2026Latest source record: Jun 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 209 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

209

Actual

Start

Oct 14, 2024

Primary completion

May 5, 2026

Study completion May 5, 2026

Sponsor

Lead sponsor
Knoa Pharma LLCIndustry
Sponsor type
Industry
Collaborators
Imbrium Therapeutics
First posted
Aug 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.

Conditions

  • Alcohol Use Disorder

Interventions

  • SunobinopDrug

    1 tablet taken orally at bedtime

  • Placebo to match sunobinopDrug

    1 tablet taken orally at bedtime

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent heavy drinking days (HDD)Time frame: Day 57

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Belmont Medical Office

    Brooklyn, New York

  • Ohio Clinical Trials

    Columbus, Ohio

  • Inquest Clinical Research

    Baytown, Texas

  • Cebis Usa, Llc

    Houston, Texas

  • Bio Terra Med SRL

    Bucharest, Romania

  • Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"

    Bucharest, Romania

  • Cabinet Medical Individual Dr. Andreea Popa

    Bucharest, Romania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.